| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA59432
Max Phase: Preclinical
Molecular Formula: C24H33NO3
Molecular Weight: 383.53
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CC(/C=C/C=C(\C)C(=O)Nc1cc(C(C)(C)C)ccc1C(C)(C)C)=C\C(=O)O
Standard InChI: InChI=1S/C24H33NO3/c1-16(14-21(26)27)10-9-11-17(2)22(28)25-20-15-18(23(3,4)5)12-13-19(20)24(6,7)8/h9-15H,1-8H3,(H,25,28)(H,26,27)/b10-9+,16-14+,17-11+
Standard InChI Key: YVPJQIVRYDIDRQ-QOZNPEFCSA-N
Associated Targets(Human)
Cellular retinoic acid-binding protein I 14 Activities
Associated Targets(non-human)
Mus musculus 284745 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Retinoic acid receptor alpha 153 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 383.53 | Molecular Weight (Monoisotopic): 383.2460 | AlogP: 5.75 | #Rotatable Bonds: 5 |
| Polar Surface Area: 66.40 | Molecular Species: ACID | HBA: 2 | HBD: 2 |
| #RO5 Violations: 1 | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
| CX Acidic pKa: 4.33 | CX Basic pKa: | CX LogP: 6.18 | CX LogD: 3.24 |
| Aromatic Rings: 1 | Heavy Atoms: 28 | QED Weighted: 0.50 | Np Likeness Score: 0.35 |
References
| 1. Shealy YF, Riordan JM, Frye JL, Simpson-Herren L, Sani BP, Hill DL.. (2003) Inhibition of papilloma formation by analogues of 7,8-dihydroretinoic acid., 46 (10): [PMID:12723955] [10.1021/jm020324t] |
Source
Source(1):